Request Deal Involvement

Sofinnova Partners and Earlybird Venture Capital led a $65m Series A round in Haya Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Linnden Communications

pr advisors

Linnden Communications

Lenz & Staehelin

legal advisors

Lenz & Staehelin

or

Principals

LIFELINK VENTURES

bidder

LIFELINK VENTURES

HAYA THERAPEUTICS SA

target

HAYA THERAPEUTICS SA

LONGVIEW VENTURES

bidder

LONGVIEW VENTURES

BERNINA BIOINVEST

bidder

BERNINA BIOINVEST

SCHRODERS CAPITAL

bidder

SCHRODERS CAPITAL

APOLLO HEALTH VENTURES

bidder

APOLLO HEALTH VENTURES

SOFINNOVA PARTNERS

bidder

SOFINNOVA PARTNERS

EARLYBIRD VENTURE CAPITAL GMBH

bidder

EARLYBIRD VENTURE CAPITAL GMBH

ELI LILLY AND COMPANY

bidder

ELI LILLY AND COMPANY

ATHOS CAPITAL

bidder

ATHOS CAPITAL

+ND CAPITAL

bidder

+ND CAPITAL

4SEE VENTURES

bidder

4SEE VENTURES

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Sofinnova Partners and Earlybird Venture Capital led a $65m Series A round in Haya Therapeutics.